Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Jul 5:8:444.
doi: 10.3389/fphar.2017.00444. eCollection 2017.

Vitamin E As a Potential Interventional Treatment for Metabolic Syndrome: Evidence from Animal and Human Studies

Affiliations
Review

Vitamin E As a Potential Interventional Treatment for Metabolic Syndrome: Evidence from Animal and Human Studies

Sok Kuan Wong et al. Front Pharmacol. .

Abstract

A constellation of medical conditions inclusive of central obesity, hyperglycemia, hypertension, and dyslipidemia is known as metabolic syndrome (MetS). The safest option in curtailing the progression of MetS is through maintaining a healthy lifestyle, which by itself, is a long-term commitment entailing much determination. A combination of pharmacological and non-pharmacological approach, as well as lifestyle modification is a more holistic alternative in the management of MetS. Vitamin E has been revealed to possess anti-oxidative, anti-inflammatory, anti-obesity, anti-hyperglycemic, anti-hypertensive and anti-hypercholesterolemic properties. The pathways regulated by vitamin E are critical in the development of MetS and its components. Therefore, we postulate that vitamin E may exert some health benefits on MetS patients. This review intends to summarize the evidence in animal and human studies on the effects of vitamin E and articulate the contrasting potential of tocopherol (TF) and tocotrienol (T3) in preventing the medical conditions associated with MetS. As a conclusion, this review suggests that vitamin E may be a promising agent for attenuating MetS.

Keywords: dyslipidemia; hyperglycemia; hypertension; metabolic syndrome; obesity; tocopherol; tocotrienol; vitamin E.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Summary of possible hypocholesterolemic and hypercholesterolemic actions of tocopherol and tocotrienol, mediated through activation or inhibition of HMG-CoA reductase activity.

References

    1. Aasheim E. T., Hofso D., Hjelmesaeth J., Birkeland K. I., Bohmer T. (2008). Vitamin status in morbidly obese patients: a cross-sectional study. Am. J. Clin. Nutr. 87, 362–369. - PubMed
    1. Aggarwal B. B., Sundaram C., Prasad S., Kannappan R. (2010). Tocotrienols, the vitamin E of the 21st century: its potential against cancer and other chronic diseases. Biochem. Pharmacol. 80, 1613–1631. 10.1016/j.bcp.2010.07.043 - DOI - PMC - PubMed
    1. Alberti K. G., Eckel R. H., Grundy S. M., Zimmet P. Z., Cleeman J. I., Donato K. A., et al. . (2009). Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120, 1640–1645. 10.1161/CIRCULATIONAHA.109.192644 - DOI - PubMed
    1. Alcala M., Sanchez-Vera I., Sevillano J., Herrero L., Serra D., Ramos M. P., et al. . (2015). Vitamin E reduces adipose tissue fibrosis, inflammation, and oxidative stress and improves metabolic profile in obesity. Obesity (Silver. Spring). 23, 1598–1606. 10.1002/oby.21135 - DOI - PubMed
    1. Allen P. S., Brown A. W., Brown M. M., Hsu W. H., Beitz D. C. (2015). Taurine and vitamin E supplementations have minimal effects on body composition, hepatic lipids, and blood hormone and metabolite concentrations in healthy Sprague Dawley rats. Nutr. Diet. Suppl. 7, 77–85. 10.2147/NDS.S88888 - DOI - PMC - PubMed